关于放射治疗和瘤系统治疗的指导方针:停止还是继续?
Chloé Buchalet1, Constance Golfier2, Jean-Christophe Faivre2
1Fédération universitaire d'oncologie radiothérapie d'Occitanie Méditerranée, Institut du cancer de Montpellier, Montpellier, France.
这份法国指南协调了将放射治疗与全身癌症治疗相结合的做法,详细说明了化学疗法,激素疗法,向疗法和免疫疗法组合的风险,放射生物学的原则和最佳时间.
科学领域:
- 在瘤学瘤学.
- 辐射瘤学 辐射瘤学
- 药理学 药理学是指药理学的学科.
背景情况:
- 将放射治疗与全身治疗相结合是标准的临床实践.
- 协调这些组合的标准实践至关重要.
- 了解组合治疗的机会和风险至关重要.
研究的目的:
- 出版法国联合放射治疗和瘤系统治疗指南的第一版.
- 总结与这些组合相关的机会和风险.
- 为结合放射治疗与各种全身疗法的最佳时间提供指导.
主要方法:
- 综合治疗的基础放射生物学的原则的审查.
- 要避免的有毒组合的识别和描述.
- 制定指导方针,以最佳时间进行放射治疗与化疗,激素治疗,向治疗和免疫治疗.
主要成果:
- 这些指南提供了一个全面的概述,将放射治疗与全身治疗相结合.
- 解释了放射生物学的关键原则.
- 详细介绍了特定的有毒组合和最佳时间推.
结论:
- 这些指导方针旨在协调将放射治疗与全身瘤治疗相结合的标准实践.
- 提供的信息有助于临床医生导航复杂性,并优化组合疗法的使用.
- 数据可以在线获取,以便更广泛地传播和应用.
更多相关视频
06:20Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
05:39Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
Published on: April 5, 2024
相关概念视频
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Cancer Survival Analysis
Tumor Immunotherapy
